According to the business intelligence report titled ‘Global In Vivo Toxicology Market Size study, by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) and Regional Forecasts 2021-2027.’, available with MarketStudyReport, global in vivo toxicology market is was evaluated at USD 5.0 billion in 2020 and is anticipated to be worth USD 7.27 billion by 2027, expanding at 5.5% CAGR between 2021-2027.
 

Surging demand for personalized medicines coupled with growing pharmaceutical R&D activities are the key factors driving global in vivo toxicology market expansion. Rising demand for humanized animal models will aid revenue inflow as well.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4219740/
 

Citing an example, Waters Corporation established Immerse Cambridge in 2020, a research laboratory in Cambridge which provides a collaborative space where the company could work on launching the next generation scientific developments using academia and research.
 

On the other hand, stringent laws and regulations regarding the ethical use of animals in research will act as a challenge for businesses operating in this domain.
 

Based on product gamut, worldwide in vivo toxicology market sphere is split into reagents & kits, and animal models. Speaking of test type, the industry is divided into sub-acute, and chronic. As per toxicity endpoints, the business space is bifurcated into immunotoxicity, and systemic.
 

Moving on to end user spectrum, the market is arrayed into contract research organizations, and academic & research institute. As per test facility, the industry is categorized into in house and outsourced segments.
 

From the regional frame of reference, North America held majority of global in vivo toxicology market share in the recent past owing to growing biomedical research in the U.S. Meanwhile, Asia Pacific market is projected to record significant expansion between 2021-2027, primarily due to availability of accurate & precise test results by clinical laboratories and rising development of multi-analyte controls.
 

Leading players shaping worldwide in vivo toxicology market dynamics are Charles River Laboratories International Inc., Shimadzu Corporation, The Jackson Laboratory, Agilent Technologies Inc., Envigo International Holdings Inc., Waters Corporation, Taconic Biosciences Inc., Danaher Corporation, JANVIER LABS, and Thermo Fisher Scientific.